Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
Clinical trial NCT05669599 · COMPLETED
Trial details
- NCT number
- NCT05669599
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-18
- Primary completion
- 2024-10-08
- Enrollment
- 592
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.